Sodium Zirconium Cyclosilicate Duration and Hyperkalemia-Related Healthcare Encounters in Patients with Heart Failure and Cardio/Renal Dysfunction: The GALVANIZE Outcome Study.

Saved in:
Bibliographic Details
Title: Sodium Zirconium Cyclosilicate Duration and Hyperkalemia-Related Healthcare Encounters in Patients with Heart Failure and Cardio/Renal Dysfunction: The GALVANIZE Outcome Study.
Authors: Agiro A; AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA. abiy.agiro@astrazeneca.com., Mu F; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Cook EE; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Greatsinger A; Analysis Group, Inc., 151 W 42nd Street, 23rd Floor, New York, NY, 10036, USA., Chen J; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Sundar M; Analysis Group, Inc., 333 S Hope St # 27, Los Angeles, CA, 90071, USA., Zhao A; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Colman E; AstraZeneca, 121 Seaport Blvd, Boston, MA, 02210, USA., Malhotra A; AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA.
Source: Drugs - real world outcomes [Drugs Real World Outcomes] 2025 Dec; Vol. 12 (4), pp. 655-667. Date of Electronic Publication: 2025 Oct 28.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2199-1154
DOI:10.1007/s40801-025-00525-7